Dajeong Lee Selected Research

4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amine

5/2019

An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dajeong Lee Research Topics

Disease

5	Hypersensitivity (Allergy) 05/2019 - 01/2016
4	Neoplasms (Cancer) 09/2020 - 12/2017
3	Anaphylaxis (Anaphylactic Shock) 05/2019 - 01/2016
2	Infections 11/2021 - 01/2015
2	Contact Dermatitis (Eczema, Contact) 10/2021 - 01/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 05/2019
2	type 2C Congenital disorder of glycosylation 11/2019 - 01/2018
2	Food Hypersensitivity (Food Allergy) 05/2018 - 01/2016
2	Inflammation (Inflammations) 01/2014 - 01/2013
2	Myocarditis (Carditis) 01/2014 - 01/2014
1	Virus Diseases (Viral Diseases) 11/2021
1	Immediate Hypersensitivity 09/2020
1	Cerebral Palsy (Spastic Diplegia) 12/2019
1	Hip Dislocation 12/2019
1	Leukemia 11/2019
1	Allergic Rhinitis 05/2019
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Diarrhea 01/2016
1	Arthritis (Polyarthritis) 01/2016
1	Fibrosis (Cirrhosis) 01/2014
1	Cardiac Arrhythmias (Arrythmia) 01/2014
1	Ventricular Tachycardia 01/2014
1	Atherosclerosis 01/2013
1	Atherosclerotic Plaque (Atheroma) 01/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2014
4	Immunoglobulin E (IgE)IBA 11/2019 - 01/2016
3	Pharmaceutical PreparationsIBA 09/2020 - 01/2018
2	AntigensIBA 11/2019 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 05/2018 - 12/2017
2	Biological ProductsIBA 01/2016 - 01/2016
1	Arginine (L-Arginine)FDA Link 11/2021
1	Lysine (L-Lysine)FDA Link 11/2021
1	Viral ProteinsIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	UbiquitinIBA 11/2021
1	entinostat (MS 275)IBA 10/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	LeukotrienesIBA 09/2020
1	Dasatinib (BMS 354825)FDA Link 09/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2020
1	src-Family KinasesIBA 09/2020
1	AminesIBA 05/2019
1	4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amineIBA 05/2019
1	Phosphotransferases (Kinase)IBA 05/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	OxazoloneIBA 01/2019
1	furaltadon (furaltadone)IBA 06/2018
1	AllergensIBA 05/2018
1	Aloe vera gelIBA 05/2018
1	OvalbuminIBA 05/2018
1	Polysaccharides (Glycans)IBA 05/2018
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 01/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018
1	Toll-Like Receptor 4IBA 12/2017
1	CytokinesIBA 10/2017
1	RadonIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	Caseins (Casein)FDA Link 01/2016
1	VaccinesIBA 01/2015
1	KN 93IBA 01/2014
1	SteroidsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2014
1	Cardiac MyosinsIBA 01/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2014
1	Receptor for Advanced Glycation End ProductsIBA 01/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2013
1	Angiotensin IIIBA 01/2013
1	ApolipoproteinsIBA 01/2013

Therapy/Procedure

1	Compression Bandages 12/2019